Loading...
Most patients who suffer ischemic strokes are eligible to receive — and benefit from — antihypertensive and lipid-lowering drugs to prevent subsequent cardiovascular and cerebrovascular events. In a study that involved nearly 13,000 patients (age, ≥50) who had strokes between 1995 and 2005 and survived ≥30 days afterward, British investigators determined the extent to which preventive drug treatment (defined as being prescribed a combination of antihypertensive and lipid-lowering drugs, with or without antithrombotic drugs) was used and how it affected 1-year mortality. The investigators assumed that all patients were eligible to receive preventive drug treatment.
Only 26% of men and 21% of women received preventive drug treatment. Multivari…